AMiAware Quantibody Cardiac Microarray
The AMiAware Human Cardiovascular Disease Array
Catalog Number AMIKIT001
For the simultaneous multiplexed quantitative detection of 13 circulating human cardiac biomarkers in plasma within the clinical target range.
Novel Multiplex MicroArray Using Evidence Based Prognostic and Diagnostic Markers Reporting the Earliest Warning of a Heart Attack and Cardiac Tissue Necrosis
|Cytokines Detected (13)||The AMiAware Panel Markers - Patents Issued|
|Format||One standard glass slide is spotted with 16 wells of identical antibody arrays. Each antibody is arrayed in quadruplicate.|
|Detection Method||Fluorescence with laser scanner: Cy3 equivalent dye|
|Sample Type||Heparin Plasma|
|Sample Volume||50-100µL per array|
|Reproducibility||CV < 20%|
|Assay Duration||3 Hours|
The AMiAware Human Cardiovascular Disease Microarray quantitatively detects 13 Circulating Cardiac Biomarkers, providing rapid and sensitive results in the required clinical range requiring only a single dilution for state-of-the-art prognostic insight on heart tissue damage. This patient-specific Signature of Disease provides critical information on the earliest changes of the coronary vessels that preclude an Acute Myocardial Infarction (AMI) or allow providers to easily monitor cardiac tissue damage after an AMI. This multiplex microarray delivers essential information for understanding processes that lead to heart tissue damage, helps guide treatment to avoid heart tissue damage, and lends critical diagnostic information to inform treatment decisions to improve cardiac function.
This product may be ordered as a kit for in-house laboratory testing or as a send-out test assayed at the XCellCure, LLC laboratory in St. Louis, MO.
|Product Name||SKU #||Product Size||List Price USD||Qty|